|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:awarded
|
gptkb:National_Medal_of_Technology_and_Innovation_(2013)
|
|
gptkbp:businessModel
|
Public
|
|
gptkbp:CEO
|
gptkb:David_A._Ricks
|
|
gptkbp:countryOfOrigin
|
gptkb:United_States
|
|
gptkbp:focusArea
|
Neuroscience
Oncology
Immunology
Diabetes
|
|
gptkbp:foundedBy
|
gptkb:Eli_Lilly
|
|
gptkbp:foundedYear
|
1876
|
|
gptkbp:fullName
|
gptkb:Eli_Lilly_and_Company
|
|
gptkbp:headquartersLocation
|
gptkb:Indianapolis,_Indiana,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lilly
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:listedOn
|
gptkb:S&P_500
gptkb:S&P_100
|
|
gptkbp:netIncome
|
$5.2 billion (2023)
|
|
gptkbp:notableProduct
|
gptkb:Humalog
gptkb:Mounjaro
gptkb:Prozac
gptkb:Trulicity
gptkb:Zyprexa
gptkb:Cialis
|
|
gptkbp:numberOfEmployees
|
approximately 41,000 (2023)
|
|
gptkbp:parentCompany
|
nan
|
|
gptkbp:revenue
|
$34.1 billion (2023)
|
|
gptkbp:stockExchange
|
gptkb:NYSE
|
|
gptkbp:stockSymbol
|
gptkb:LLY
|
|
gptkbp:subsidiary
|
gptkb:Elanco
gptkb:ImClone_Systems
|
|
gptkbp:website
|
https://www.lilly.com/
|
|
gptkbp:bfsParent
|
gptkb:The_Crow:_Wicked_Prayer
|
|
gptkbp:bfsLayer
|
5
|